Contact
Please use this form to send email to PR contact of this press release:
VistaGen Therapeutics Receives FDA Fast Track Designation for AV-101 for the Treatment of Major Depressive Disorder
TO:
Please use this form to send email to PR contact of this press release:
VistaGen Therapeutics Receives FDA Fast Track Designation for AV-101 for the Treatment of Major Depressive Disorder
TO: